Powder: -20°C for 3 years | In solvent: -80°C for 2 years
NBI-921352 is a blocker of Sodium Channel protein type 8 subunit alpha and can be used in studies about nervous system pathologies of epilepsy treatment.
説明 | NBI-921352 is a blocker of sodium channel protein type 8 subunit alpha and can be used in studies about nervous system pathologies of epilepsy treatment. |
別名 | XEN901, NBI-921352 |
分子量 | 460.59 |
分子式 | C22H25FN4O2S2 |
CAS No. | 2154406-04-7 |
Powder: -20°C for 3 years | In solvent: -80°C for 2 years
DMSO: 112.5mg/mL (244.3mM), Need ultrasonic
( < 1 mg/ml refers to the product slightly soluble or insoluble )
You can also refer to dose conversion for different animals. 詳細
bottom
Please see Inhibitor Handling Instructions for more frequently ask questions. Topics include: how to prepare stock solutions, how to store products, and cautions on cell-based assays & animal experiments, etc.
Zandatrigine 2154406-04-7 Membrane transporter/Ion channel Sodium Channel XEN901 NBI-921352 Inhibitor inhibitor inhibit